Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kineticos Life Sciences is a venture capital firm based in Raleigh, North Carolina, specializing in the life sciences sector. Founded to partner with companies that improve patient outcomes, Kineticos focuses on high-growth opportunities in biotech and healthcare. The firm invests across various stages, from pre-seed to growth equity, with a particular emphasis on early-stage innovators.
Kineticos invests in the life sciences ecosystem, targeting specialized pharmaceutical services, oncology, neurodegenerative diseases, rare diseases, and antimicrobial resistance. The firm typically backs companies at various stages of development, primarily within the United States, with a strategy centered on high-growth potential.
Notable companies in Kineticos' portfolio include Amylyx, focused on therapeutics for neurodegenerative disorders; Arranta Bio, a CDMO specializing in microbiome and mRNA therapies; Clarametyx, developing anti-biofilm antibodies for cystic fibrosis; DIANT Pharma, known for continuous processing technology for nanoparticles; Endolytix, which treats non-tuberculous mycobacterial pulmonary disease; and EnteroBiotix, focused on therapeutics for hepatic encephalopathy.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.